Neuromuscular cardiopulmonary medicine is entering a new and exciting phase, with studies that assess the respiratory effect of emerging genetic and molecular therapies. In this year's neuromuscular Year in Review, we focus on Duchenne muscular dystrophy (DMD), reviewing studies that evaluate the respiratory effect of eteplirsen, the cardiopulmonary effects of ataluren, and a study comparing the use of spironolactone with eplerenone for the treatment of DMD-related cardiomyopathy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ppul.24970 | DOI Listing |
Publication Analysis
Top Keywords
year review
8
review 2019
4
2019 neuromuscular
4
neuromuscular diseases
4
diseases neuromuscular
4
neuromuscular cardiopulmonary
4
cardiopulmonary medicine
4
medicine entering
4
entering exciting
4
exciting phase
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!